APA (7th ed.) Citation

LM, K., E, Y., H, Z., S, Y., E, Y., J, C., . . . CL, A. (2026). Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype. Journal of bone oncology, 57, 100754. https://doi.org/10.1016/j.jbo.2026.100754

Chicago Style (17th ed.) Citation

LM, Kreps, Yakubovich E, Zhao H, Yimer S, Yang E, Cruz J, Vanderhyden B, and Addison CL. "Doxorubicin Enhances Adipogenesis in an FGF2-dependent Manner and Induces a Tumour-promoting Secretory Phenotype." Journal of Bone Oncology 57 (2026): 100754. https://doi.org/10.1016/j.jbo.2026.100754.

MLA (9th ed.) Citation

LM, Kreps, et al. "Doxorubicin Enhances Adipogenesis in an FGF2-dependent Manner and Induces a Tumour-promoting Secretory Phenotype." Journal of Bone Oncology, vol. 57, 2026, p. 100754, https://doi.org/10.1016/j.jbo.2026.100754.